文献速递心脏核医学

瑞加诺生负荷SPECT心肌灌注显像中ST段与T波异常对预后的影响

The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging.
PubMed 文献 · J Nucl Cardiol · 2020-10-08

本研究为单中心回顾性队列,纳入6059例接受瑞加诺生负荷SPECT-MPI且无已知冠心病、基线心电图可判读ST/T的患者,按ST/T异常分型分析MACE。中位随访2.3±1.9年,继发性ST/T异常者MACE风险显著高于心电图正常者,但该类患者中MPI异常或心肌缺血未增加MACE;原发性ST异常和T波异常者整体MACE风险未显著升高,但MPI异常或心肌缺血与更高MACE相关。

要点

  • 继发性ST/T异常者MACE风险显著高于心电图正常者(HR 2.05)。
  • 继发性ST/T异常者中,MPI异常或心肌缺血未显著增加MACE。
  • 原发性ST异常或T波异常者中,MPI异常或心肌缺血与更高MACE相关。

核心结论

  • 继发性ST/T异常患者MACE风险显著升高,但该类患者中MPI异常或心肌缺血不增加预后信息。
  • 原发性ST异常和T波异常患者整体MACE风险未显著高于心电图正常者,但MPI异常或心肌缺血与更高MACE相关。

研究设计与样本

  • 单中心回顾性队列研究,连续纳入接受瑞加诺生负荷SPECT-MPI的患者。
  • 排除基线心电图异常妨碍ST/T分析者及已知冠心病患者。
  • 共纳入6059例受试者,其中1912例(32%)存在基线ST/T异常。
  • 按心电图分为原发性ST异常、继发性ST/T异常(心室肥厚或右束支传导阻滞所致)、T波异常或正常心电图。
  • 主要结局为主要不良心血管事件(MACE),定义为心源性死亡或心肌梗死的复合终点。

主要发现

  • 平均随访2.3±1.9年,继发性ST/T异常者MACE发生率显著高于心电图正常者(HR 2.05;95%CI 1.04-4.05;P=0.039)。
  • 原发性ST异常者与心电图正常者相比MACE无显著差异(HR 1.64;95%CI 0.87-3.06;P=0.124)。
  • T波异常者与心电图正常者相比MACE无显著差异(HR 1.15;95%CI 0.62-2.16;P=0.658)。
  • 继发性ST/T异常者中,MPI异常与正常MPI相比MACE无显著增加(HR 1.18;95%CI 0.31-4.58;P=0.808)。
  • 原发性ST异常者中,MPI异常与更高MACE相关(HR 4.50;95%CI 1.44-14.10;P=0.005);T波异常者中MPI异常与更高MACE相关(HR 3.74;95%CI 1.20-11.68;P=0.015)。

关键数值与推荐

  • 继发性ST/T异常者中,瑞加诺生负荷SPECT-MPI心肌缺血与MACE无显著相关(HR 1.45;95%CI 0.38-5.61;P=0.588)。
  • 原发性ST异常者中,瑞加诺生负荷SPECT-MPI心肌缺血与更高MACE相关(HR 3.012;95%CI 0.95-9.53;P=0.049)。
  • T波异常者中,瑞加诺生负荷SPECT-MPI心肌缺血与更高MACE相关(HR 5.06;95%CI 1.60-15.96;P=0.002)。

临床怎么用

  • 对继发性ST/T异常患者,应重视其基线MACE高风险,但MPI异常或心肌缺血对该组预后分层价值有限。
  • 对原发性ST异常或T波异常患者,MPI异常或心肌缺血提示更高MACE风险,可据此加强风险分层与随访。

局限性

  • 本研究为单中心回顾性队列研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prognostic implications of ST-segment and T-wave (ST/T) abnormalities in patients undergoing stress SPECT-myocardial perfusion imaging (MPI) are not well defined. METHODS AND RESULTS: This was a single-center, retrospective cohort study of consecutive patients who underwent regadenoson stress SPECT-MPI. Patients with baseline electrocardiogram (ECG) abnormalities that impede ST/T analysis or those with known coronary artery disease were excluded. Patients were categorized as having primary ST abnormalities, secondary ST/T abnormalities due to ventricular hypertrophy or right bundle branch block, T-wave abnormalities, or normal ECG. The primary outcome was major adverse cardiovascular events (MACE) defined as the composite of cardiac death or myocardial infarction. Among 6,059 subjects, 1912 (32%) had baseline ST/T abnormalities. During a mean follow-up of 2.3 ± 1.9 years, the incidence of MACE was significantly higher among patients with secondary ST/T abnormalities compared to those with normal ECG (HR 2.05; 95% confidence interval [CI], 1.04-4.05; P = 0.039). No significant difference in MACE was observed among patients with primary ST abnormalities (HR 1.64; CI 0.87-3.06; P = 0.124) or T-wave abnormalities (HR 1.15; CI 0.62-2.16; P = 0.658) compared with patients who had normal ECG. Among patients with secondary ST/T changes, abnormal MPI was not associated with a significant increase in MACE rates compared to normal MPI (HR 1.18; CI 0.31-4.58; P = 0.808). However, abnormal MPI was associated with higher MACE rates among patients with primary ST abnormalities (HR 4.50; CI 1.44-14.10; P = 0.005) and T-wave abnormalities (HR 3.74; CI 1.20-11.68; P = 0.015). Similarly, myocardial ischemia on regadenoson stress SPECT-MPI was not associated with a significant increase in MACE rates in patients with secondary ST/T abnormalities (HR 1.45; CI 0.38-5.61; P = 0.588), while it was associated with a higher incidence of MACE in patients with primary ST abnormalities (HR 3.012; CI 0.95-9.53; P = 0.049) and T-wave abnormalities (HR 5.06; CI 1.60-15.96; P = 0.002). CONCLUSION: While patients with secondary ST/T abnormalities had significantly higher MACE risk, abnormal MPI or presence of myocardial ischemia on regadenoson SPECT-MPI in this group does not add prognostic information. Patients with primary ST abnormalities and T-wave abnormalities do not seem to have a significantly higher MACE risk compared to those with normal ECG; however, abnormal MPI or presence of myocardial ischemia, in these groups, correlates with higher MACE rates.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Khan MS, Arif AW, Doukky R, et al. The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging. J Nucl Cardiol. 2020. PMID: 33034037. doi:10.1007/s12350-020-02382-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。